A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Study Number

2642122

Phase

Age Group

Adult

Principal Investigator

Purpose

The purpose of this study is to collect long-term follow-up data on delayed adverse events after administration of ciltacabtagene autoleucel (cilta-cel), and to characterize and understand the long-term safety profile of cilta-cel.

Check your eligibility for this trial

Check now

Full Title

A Long-term Follow-up Study for Participants Previously Treated with Ciltacabtagene Autoleucel in company-sponsored clinical studies

ClinicalTrials.Gov ID

NCT05201781

Get more information and eligibility criteria for this trial at ClinicalTrials.gov

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.